• Close

    • Critical Care
    • Health Policy Journal Club
    • Program Director Interviews

Michael Perza, PharmD, BCPS

Mike Perza.jpeg

Emergency Medicine Clinical Pharmacist
ChristianaCare

CRASH-3 Anchor Image.jpg
Critical Care , Critical Care Alert

Critical Care Alert: CRASH-3 Review of TXA for TBI

12/16/2019 Ryan Lee, MD , Raymond Green, DO, FACS , Michael Perza, PharmD, BCPS
Released in October 2019, CRASH-3 is the latest trial exploring the benefits of tranexamic acid, this time in traumatic brain injury. The bottom line: TXA hasn't been shown to reduce mortality.

© 2021 Emergency Medicine Residents' Association | Privacy Policy | Website Links Policy | Social Media Policy

CHAT NOW
CHAT OFFLINE